5 Evidence for Efficacy of Migraine Surgery

May 20, 2020 by in NEUROSURGERY Comments Off on 5 Evidence for Efficacy of Migraine Surgery

10.1055/b-0038-161686 5 Evidence for Efficacy of Migraine SurgeryBahman Guyuron Salient Points The first research on current migraine surgery was prompted by two patients who reported their migraine headaches (MHs) ceased…

read more

2 An Overview of Migraine Headaches

May 20, 2020 by in NEUROSURGERY Comments Off on 2 An Overview of Migraine Headaches

10.1055/b-0038-161683 2 An Overview of Migraine HeadachesHossein Ansari Salient Points Migraine headache is the most common neurological disorder and one of the most common pain conditions, in addition to being…

read more

1 History of Migraine Surgery

May 20, 2020 by in NEUROSURGERY Comments Off on 1 History of Migraine Surgery

10.1055/b-0038-161682 1 History of Migraine SurgeryBahman Guyuron Salient Points Scalding of the forehead in an attempt to treat frontal migraine headaches (MHs) during the 10th century is the first ablative…

read more

19 Botulinum Neurotoxin for Sialorrhea

May 4, 2020 by in NEUROLOGY Comments Off on 19 Botulinum Neurotoxin for Sialorrhea

10.1055/b-0040-175242 19 Botulinum Neurotoxin for SialorrheaBrianna K. Crawley, Scott M. Rickert, Senja Tomovic, and Andrew Blitzer Summary Sialorrhea can be a debilitating sequela of some neurologic disorders. Botulinum neurotoxin (BoNT)…

read more

12 Botulinum Neurotoxin for Temporomandibular Disorders, Masseteric Hypertrophy, and Cosmetic Masseter Reduction

May 4, 2020 by in NEUROLOGY Comments Off on 12 Botulinum Neurotoxin for Temporomandibular Disorders, Masseteric Hypertrophy, and Cosmetic Masseter Reduction

10.1055/b-0040-175235 12 Botulinum Neurotoxin for Temporomandibular Disorders, Masseteric Hypertrophy, and Cosmetic Masseter ReductionMichael Z. Lerner and Andrew Blitzer Summary Temporomandibular disorder (TMD) and associated masticatory muscle hyperfunction often result in…

read more

17 Botulinum Neurotoxin for Frey Syndrome

May 4, 2020 by in NEUROLOGY Comments Off on 17 Botulinum Neurotoxin for Frey Syndrome

10.1055/b-0040-175240 17 Botulinum Neurotoxin for Frey SyndromeRachel Kaye, Andrew Blitzer, and Brian E. Benson Summary Frey syndrome (FS) describes facial hyperhidrosis, erythema, or warmth encouraged by gustatory stimuli. It is…

read more

14 Botulinum Neurotoxin for Migraine

May 4, 2020 by in NEUROLOGY Comments Off on 14 Botulinum Neurotoxin for Migraine

10.1055/b-0040-175237 14 Botulinum Neurotoxin for MigraineRachel Kaye, Jerome S. Schwartz, Brian E. Benson, and William J. Binder Summary Migraine is a leading cause of disability in the United States and…

read more

16 Botulinum Neurotoxin for Trigeminal Neuralgia

May 4, 2020 by in NEUROLOGY Comments Off on 16 Botulinum Neurotoxin for Trigeminal Neuralgia

10.1055/b-0040-175239 16 Botulinum Neurotoxin for Trigeminal NeuralgiaElizabeth Guardiani, Andrew Blitzer, Lesley French Childs, and Ronda E. Alexander Summary Trigeminal neuralgia (TN) is a unilateral facial pain disorder characterized by brief,…

read more

18 Botulinum Neurotoxin for Facial Hyperhidrosis

May 4, 2020 by in NEUROLOGY Comments Off on 18 Botulinum Neurotoxin for Facial Hyperhidrosis

10.1055/b-0040-175241 18 Botulinum Neurotoxin for Facial HyperhidrosisDiana N. Kirke, Daniel Novakovic, and Andrew Blitzer Summary Hyperhidrosis is characterized by excess perspiration and may be primary/idiopathic or secondary due to endocrine…

read more
Get Clinical Tree app for offline access